Pattern Recognition Receptors and HBV Infection

Slides:



Advertisements
Similar presentations
1. Interpret a positive HBeAg, Anti- HBcAg, and/or anti-HCV test.
Advertisements

CORRELATION BETWEEN HBSAG LEVEL AND VIRAL LOAD
Tumoricidal activity of human dendritic cells
Lecture outline The nomenclature of Immunology Types of immunity (innate and adaptive; active and passive; humoral and cell- mediated) Features of immune.
Major question: Recognition of microbes by dendritic cells (via TLRs) is essential to activate the adaptive response Viruses can be strictly intracellular.
T cells Jan Novák. The immune system Protection against infectious agents Clearance of dying, damaged and dangerous cells Regulation of the immune responses.
Immunology of HPV Infection Craig Woodworth Department of Biology Clarkson University Potsdam, NY.
Biochemical Markers in the inflammatory response Dr Claire Bethune Consultant Immunologist Derriford Hospital.
Design of immune system Immune system Self/non-self recognition The state of protection from infectious disease 自我非我 Memory Acceptance vs rejection 疫苗.
Kerriann Parchment GI CBL 2 Part 3 December 2012 Viral hepatitis serology.
Danielle V. Reenstra York College of Pennsylvania, Department of Biological Sciences The Interferon Response to Epstein-Barr Virus Virus containing supernatant.
Research on HBV in SCDC Xi Zhang, Ye Lu Shanghai Municipal Center for Disease Control and Prevention May, 2008.
Α-Interferon to Hepatitis B Lecturer: Sun fengkai Team members : Qixin Jiaming Songhaiyang Yulingqi Zhangwen Zhaoliang.
Dendritic Cells – Target of HNSCC Immune Escape can be supported with PAMP´s Barbara Wollenberg Universitätsklinikum Schleswig-Holstein, Campus Lübeck.
Toll-Like Receptors in CNS Viral Infections Unclear role of TLRs in natural infections TLR3, -7, -8, -9 recognize viral nucleic acids. Localized intracellularly.
House dust mite (HDM) is a common allergen and reactivity is associated with asthma and atopic dermatitis. The development of these allergic diseases depends.
INNATE IMMUNITY II.
Gui-Qiang Wang Department of Infectious Diseases
Treating HBV Infection: Sustained Remission with Immune control Joseph Sung MD, PhD Department of Medicine and Therapeutics Institute of Digestive Diseases.
MICR 304 Immunology & Serology Lecture 6 NK Cells, Lymphocytes Chapter 1.4 –1.17; 2.30 – 2.33 Lecture 6 NK Cells, Lymphocytes Chapter 1.4 –1.17; 2.30 –
Viral mechanisms for subversion of specific immune responses How viruses think?
Hepatitis B The Basics David Wong University of Toronto March 2005.
Discussion HBV Flare AWACC Pathogenesis of HBV CLDx Hepatic damage  predominantly immune mediated - cytotoxic T cells HBV specific peptides presented.
PROFESSIONAL ANTIGEN PRESENTING CELLS
Effects of Glutamine on the Inflammatory Response of Pulmonary Epithelial Cells Yu-Chen Hou and Sung-Ling Yeh School of Nutrition and Health Sciences,
Investigating the role of exosomes in plasmacytoid DC mediated tolerance Ulf Gehrmann, fil.mag., Biomedicine I.Hypothesis & Objectives II.Background III.Methods.
Lecture 6 clinical immunology Cytokines
NAJRAN UNIVERSITY College of Medicine NAJRAN UNIVERSITY College of Medicine Microbiology &Immunology Course Lecture No. 15 Microbiology &Immunology Course.
Evaluation of Hepatitis B surveillance system in Armenia, 2014 AUTHORS Karine Gevorgyan Lusine Paronyan Shushan Sargsyan Artavazd Vanyan NCDC, Armenia.
Dendritic Cell Subsets June 3, 2005 MIMG 261 Stephan Krutzik, Ph.D.
Milan J. Sonneveld,1 Bettina E. Hansen, Teerha Piratvisuth, Ji-Dong Jia, Stefan Zeuzem, Edward Gane, Yun-Fan Liaw, Qing Xie, E. Jenny Heathcote, Henry.
The Role of Gut Microbiota in Non-alcoholic Fatty Liver Disease
Side Scatter Forward Scatter Lineage CD1c CD141 CD303 lineage negative
Rationale, aim and conculsion
Dr Iyat Abdul Sattar A study on the clinical & serolological markers of HBV among patients with chronic HBV infection in Babylon Dr Monem Makki Alshok.
Vitamin D3 treatment of vitamin D–insufficient asthmatic patients does not alter immune cell function  Brandy Reid, MS, Pierre-Olivier Girodet, MD, PhD,
STAT4 Knockout Mice Are More Susceptible to Concanavalin A–Induced T-Cell Hepatitis  Yan Wang, Dechun Feng, Hua Wang, Ming-Jiang Xu, Ogyi Park, Yongmei.
FREQUENCIES AND PHENOTYPIC CHANGES OF DENDRITIC CELLS DURING ACUTE DENGUE VIRAL INFECTION Lertjuthaporn S1, Khowawisetsut L2, Keawvichit R1, Thitilertdecha.
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
Mononuclear phagocytes in Immune Defence
Immune Responses to HCV and Other Hepatitis Viruses
The beauty of TLR agonists for CTCL
Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection by Robert S. Welner, Rosana Pelayo, Yoshinori.
The Aging Liver in the Aging HIV and HCV Patients
by Lianne van de Laar, Aniek van den Bosch, André Boonstra, Rekha S
Hepatitis Primary Care: Clinics in Office Practice
Volume 137, Issue 4, Pages (October 2009)
Agustín Albillos, Margaret Lario, Melchor Álvarez-Mon 
Volume 135, Issue 6, Pages (December 2008)
Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis.
Natural history of hepatitis B
Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages  Patrick M. Brunner, MD, Frieder Koszik,
Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15 by Maria Wysocka, Bernice M. Benoit, Sarah.
Volume 137, Issue 6, Pages e2 (December 2009)
Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance  Oscar Palomares, PhD,
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection by.
FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.
Volume 153, Issue 5, Pages e2 (November 2017)
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
Vitamin D3 treatment of vitamin D–insufficient asthmatic patients does not alter immune cell function  Brandy Reid, MS, Pierre-Olivier Girodet, MD, PhD,
Volume 53, Issue 4, Pages (October 2010)
Volume 137, Issue 5, Pages (November 2009)
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
Volume 140, Issue 2, Pages e4 (February 2011)
Volume 144, Issue 2, Pages (February 2013)
In Vivo Role of pDCs in Regulating Adaptive Immunity
Volume 143, Issue 6, Pages e8 (December 2012)
Tobias R. Kollmann, Ofer Levy, Ruth R. Montgomery, Stanislas Goriely 
Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis
HBeAg seroconversion is associated with a more effective PD-L1 blockade during chronic hepatitis B infection  Sara Ferrando-Martinez, Kelly Huang, Angie.
Presentation transcript:

Pattern Recognition Receptors and HBV Infection Role of Toll-like Receptors Dept of Infectious Diseases Shanghai Ruijin Hospital Jiaotong University School of Medicine Qing Xie

HBV infection is still a major global health care problem High prevelance Widely spread HBsAg rate (%) 8: high 2-7: medium <2: low 350 million chronic carriers worldwide 9th leading causes of death 75% of HBV carrier are Asian

Nature History of HBV Infection HCC HBV Virons 5年 6-15% 3-5% Adult 12-20% Acute HBV Infection Chronic HBV Infection Chronic Hepatitis B Cirrhosis 5年 95% Children 5年 20-23% Antiviral treatment Liver Failure Complete Response Partially Response Non Response Immune as a key factor influences the outcome and progression of disease

Challenge: What mechanism of virus clearance of host?? How to do that?? Virus clearance resolved H O S T Central Role HBV Unable to clear virus Immune function of Host Persistent infection Progression of disease

Three essential elements required in liver inflammation following HBV infection HBV VIRONS IMMUNOCYTES HEPATOCYTES

Non antigen specific-INNATE IMMUNITY NK/T Phagocytes NK pDC Plasmacytoid DC Antigen specific-ADAPTIVE IMMUNITY LINK Cytokines Type I interferon IL-12 Granzyme B mDC Myeloid DC Antigen presentation CD8 B Th17 CD4 Tregs CD4+CD25+ Treg cell 调节性T细胞

Host HBV Virons Type I IFN Induction Activated Cytotoxic Response Virus Clearance Activated Cytotoxic Response Host Immune Response is mediated by Pattern Recognition Receptors(PRR) which recognizes specific molecular or replication intermediator of virus particles.

Pattern Recognition Receptors(PRR)

Recent Studies found: The close relationship between host innate immunity and the recognition of pathogen and clearance. TLR as an important PRR,plays a central role in defence of virus invasion. Different TLR can recognize various pathogen.

G+bacteria G-bacteria Virus clearance

What is a role of TLR in HBV infection?? G+bacteria G-bacteria Disturbance of TLR expression induces the persistent infection. Abnormal of signal passway initiated by TLR induces the inability to clear HBV or overclearance, that leads to immunotolerance or immune injury. Virus clearance

Requirement of DC involment in TLR-initiated antivirus response Toll-like receptor (TLR)-mediated recognition of specific structures of invading pathogens initiates innate as well as adaptive immune responses via antigen-presenting cells (APCs). DC represents the most potent antigen-presenting cells and thus plays an important role in the induction of innate and specific immune response.

Distribution of TLR on DCs mDC: (myeloid dendritic cell,mDC) ( CD3、CD14、CD16、CD19、CD20、CD56) -BDCA1(CD1c)+ CD11c+ TLR1 TLR2 TLR3 TLR4 TLR5 TLR6 TLR8 pDC:(plasmacytoid dendritic cell, pDC) ( CD3、CD14、CD16、CD19、CD20、 CD56)-BDCA2+ BDCA4+ CD123+ TLR7 TLR9 TLR3、TLR7、TLR9 参与抗病毒免疫

Scientific Questions? Function of Myeloid and Plasmacytoid Dendritic Cells of Patients with CHB?? Expression of TLR-3, TLR-9 in patients following HBV chronic infection??

Study Populations CHB: 28 cases Healthy:22 cases Including criteria: (1)  Serum HBsAg positive > 6 months. (2)  Abnormal liver function for 2 times with 2 weeks apart, ALT>1.5 xU/L at screeing. (3)  Serum HBeAg(+),HBeAb(-). (4)  Serum HBV-DNA>1×105 /L. (5)  excluded liver cirrhosis by liver ultrasound (6)  excluded HIV、HCV、HDV、HEV coinfection. (7)  Not allowed to use antiviral treatment or immunmodulator within 6 months.

Selection and preparation of pDC、mDC BDCA4 DC isolation kir mDC BDCA1 DC siolation kit

p>0.05 p<0.05 125 600 100 500 75 400 positive cell % MFI 300 50 200 25 100 patients controls patients controls n=28 n=18 n=28 n=18 Fig.3. TLR9 expression of isolated peripheral precursor pDCs of chronic HBV patients (n=28) and healthy controls (n=18). (A) No difference in the percentage of pDCs expressing TLR9 was found between the patients and the controls. (B) The MFI of TLR9 from patients were significantly reduced compared to controls. Data are expressed as mean±SD

A B C Fig.4. Flow cytometric analysis for enumeration of pDCs. PBMCs were isolated and stained with the following antibodies:Lin-FITC( CD3,CD14, CD16,CD19,CD20,CD56), PE-BDCA-2, and APC-CD123. (A) Dead cells were excluded by forward side scatter analysis. (B) After gating on the lineage marker-negative fraction (R2), (C) the CD123/BDCA-2-double positive represents the plasmacytoid dendritic cells.

A B p<0.05 0.0 0.1 0.2 0.3 0.4 0.5 100 200 300 400 500 600 r =-0.646 p=0.02 pDC/PBMC% ALT??(IU/L) 0.75 0.50 pDC frequency% 0.25 0.00 CHB NS n=21 n=26 Fig.5. (A)In patients with CHB the relative numbers of pDCs were significantly reduced compared healthy controls(P<.05). (B) Correlation of the relative frequency of pDCs with the ALT levels in chronic HBV infection. The relative counts of pDCs were inversely correlated with ALT values ( P<.05; r﹦-0.645).

A B C 4500 4000 3500 3000 2500 IFNa(pg/L) 2000 1500 1000 500 PBMC PBMC-pDC n=22 n=22 Fig.6. pDCs were the main source of IFN-αin the peripheral blood of humans. (A) An example of frequency analysis of pDCs in PBMCs. (B) PBMCs were analyzed by flow cytometer which showed pDCs were almost depleted. (C) PBMCs were separated with magnetic beads coupled to BDCA-4 antibodies and both fractions were stimulated with CpG-ODN 2216 , which show great amount of IFN-αin the supernatant of the BDCA-4-positive fraction compared to the BDCA-4-negative fraction.

A B C 10000 20000 30000 patients n=22 controls n=20 p<0.05 IFN-a pg/ml 1000 2000 patients n=22 controls n=20 p>0.05 TNF pg/ml 1000 2000 3000 p>0.05 patients n=22 controls n=20 IL-6 pg/ml Fig.7. Cytokine production by isolated peripheral precursor pDCs of chronic HBV patients (n=22) and healthy controls (n=20) after stimulation with CpG-ODN 2216. After 24 hours of stimulation, cytokine production was determined in the culture supernatants by specific ELISAs. (A) pDCs of patients were significantly impaired in their ability to produce IFN-αcompared to healthy controls. No difference was detected in the production of (B) TNF-αand (C) IL-6 between patients and healthy controls.

The decrease of TLR9 expression ability by DC is related to HBV infection in DC? Hepatology 2006;43(3):539-547 HBsAg HBcAg

CONCLUSIONS 1. The TLR9 expression of circulating pDCs is reduced in patients with CHB. 2. pDCs are functionally impaired with the lower ability to produce IFN-α in patients, that may partly contribute to hepatitis B evading an adequate immune response, resulting in HBV persistent infection in host. 3. HBsAg and HBcAg were detectable in pDCs of patients suggest that functional impairment of pDCs may correlate with HBV infection of pDCs.

0h 12h 0h 12h 24h 48h 24h 48h Fig8. The levels of TLR3 expression on mDC of peripherial blood between contrl and patients. It shows that TLR3 level in control is increased following 24 hrs stimulaton, however the increase of TLR3 expression was delayed to 48 hrs following stimulation. P<0.05。

* * Fig9. The changes of TLR3 mRNA by real-time PCR at various timepoints following stimulation.It shows TLR3 mRNA is increased significantly at 12 hrs, it recovers to the baseline at 24 hrs and 48 hrs. However the increase of TLR3 mRNA in CHB patients was observed at 48 hrs. *P<0.05。

* Fig10. Expression of TBK1 mRNA on mDC by RT-PCR. There is no difference in TBK1 mRNA at baseline between control and patients (P>0.05)。TBK1 mRNA is increased significantly at 12 hrs when compared to baseline in control (P<0.05). There is no difference in TBK1 mRNA at 12hrs, 24hrs and 48hrs when conpared to baseline (P>0.05)。

* Fig11. Expression of IFN-βmRNA by RT-PCR in mDC. There is no difference in at baseline between control and patients (P>0.05)。The level of IFN-βmRNA expression at 12 hrs is higher than at baseline in control (P<0.05). However there is no deifference between at various time points(P>0.05)。

* Fig12. The detection of IFN-β by ELISA in supernatant on mDC following polyI:C stimulation.The level of IFN-β at baseline is very similar between two groups.There is no difference at various timepoints following stimulation in patients.However,the level of IFN-βis much higher at 12 hrs when compared to baseline.Also the difference was observed at 12hrs, 24hrs and 48 hrs between control and patients.

CONCLUSIONS The increase of expression level of TLR3 is slower and delayed in CH groups than HV groups. It contributes to the inability for the host to clear HBV. The level of TBK1 molecular is quite low even following dsRNA stimulation, suggesting that abnormal of signal transduction passway may exist in HBV . Our results suggest that dysfunction of TLR3 might play an important role in chronic HBV infection. It may provide new insights for understanding the mechanism of persistent HBV infection